FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2248598351> ?p ?o ?g. }

• W2248598351 endingPage "761" @default.
• W2248598351 startingPage "755" @default.
• W2248598351 abstract "The anorexic agent fenfluramine considerably increases the risk of primary pulmonary hypertension. The mechanism of this effect is unknown. The appetite-reducing action of fenfluramine is mediated by its interaction with the metabolism of serotonin [5-hydroxytryptamine (5-HT)] in the brain. We tested the hypothesis that the pulmonary vasoconstrictive action of fenfluramine is at least in part mediated by 5-HT receptor activation. In addition, we sought to determine whether pharmacological reduction of voltage-gated potassium (K(V)) channel activity would potentiate the pulmonary vascular reactivity to fenfluramine. Using isolated rat lungs perfused with Krebs-albumin solution, we compared the inhibitory effect of ritanserin, an antagonist of 5-HT(2) receptors, on fenfluramine- and 5-HT-induced vasoconstriction. Both 5-HT (10(-5) mol/l) and fenfluramine (5 x 10(-4) mol/l) caused significant increases in perfusion pressure. Ritanserin at a dose (10(-7) mol/l) sufficient to inhibit >80% of the response to 5-HT reduced the response to fenfluramine by approximately 50%. A higher ritanserin dose (10(-5) mol/l) completely abolished the responses to 5-HT but had no more inhibitory effect on the responses to fenfluramine. A pharmacological blockade of K(V) channels by 4-aminopyridine (3 x 10(-3) mol/l) markedly potentiated the pulmonary vasoconstrictor response to fenfluramine but was without effect on the reactivity to 5-HT. These data indicate that the pulmonary vasoconstrictor response to fenfluramine is partly mediated by 5-HT receptors. Furthermore, the pulmonary vasoconstrictor potency of fenfluramine is elevated when the K(V)-channel activity is low. This finding suggests that preexisting K(V)-channel insufficiency may predispose some patients to the development of pulmonary hypertension during fenfluramine treatment." @default.
• W2248598351 created "2016-06-24" @default.
• W2248598351 creator A5016059750 @default.
• W2248598351 creator A5018439413 @default.
• W2248598351 creator A5041397654 @default.
• W2248598351 creator A5042701425 @default.
• W2248598351 creator A5072570716 @default.
• W2248598351 date "2001-08-01" @default.
• W2248598351 modified "2023-10-17" @default.
• W2248598351 title "Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels" @default.
• W2248598351 cites W134363133 @default.
• W2248598351 cites W1753089048 @default.
• W2248598351 cites W1963521376 @default.
• W2248598351 cites W1971056599 @default.
• W2248598351 cites W1978353628 @default.
• W2248598351 cites W1985321294 @default.
• W2248598351 cites W1987425562 @default.
• W2248598351 cites W1993199803 @default.
• W2248598351 cites W1996588278 @default.
• W2248598351 cites W1997740633 @default.
• W2248598351 cites W2007235190 @default.
• W2248598351 cites W2007685722 @default.
• W2248598351 cites W2009590071 @default.
• W2248598351 cites W2010364329 @default.
• W2248598351 cites W2014466515 @default.
• W2248598351 cites W2014609720 @default.
• W2248598351 cites W2019345683 @default.
• W2248598351 cites W2029702248 @default.
• W2248598351 cites W2037940093 @default.
• W2248598351 cites W2039738897 @default.
• W2248598351 cites W2043030209 @default.
• W2248598351 cites W2054549715 @default.
• W2248598351 cites W2057492153 @default.
• W2248598351 cites W2057503806 @default.
• W2248598351 cites W2079495255 @default.
• W2248598351 cites W2093045815 @default.
• W2248598351 cites W2099237963 @default.
• W2248598351 cites W2103857474 @default.
• W2248598351 cites W2106319447 @default.
• W2248598351 cites W2111156355 @default.
• W2248598351 cites W2125510118 @default.
• W2248598351 cites W2128270335 @default.
• W2248598351 cites W2134362869 @default.
• W2248598351 cites W2228139916 @default.
• W2248598351 cites W2282354217 @default.
• W2248598351 cites W2329065056 @default.
• W2248598351 cites W2338418415 @default.
• W2248598351 cites W2380610527 @default.
• W2248598351 cites W2988610037 @default.
• W2248598351 cites W4299634703 @default.
• W2248598351 cites W58278584 @default.
• W2248598351 doi "https://doi.org/10.1152/jappl.2001.91.2.755" @default.
• W2248598351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11457791" @default.
• W2248598351 hasPublicationYear "2001" @default.
• W2248598351 type Work @default.
• W2248598351 sameAs 2248598351 @default.
• W2248598351 citedByCount "32" @default.
• W2248598351 countsByYear W22485983512012 @default.
• W2248598351 countsByYear W22485983512013 @default.
• W2248598351 countsByYear W22485983512014 @default.
• W2248598351 countsByYear W22485983512015 @default.
• W2248598351 countsByYear W22485983512016 @default.
• W2248598351 countsByYear W22485983512017 @default.
• W2248598351 countsByYear W22485983512018 @default.
• W2248598351 countsByYear W22485983512023 @default.
• W2248598351 crossrefType "journal-article" @default.
• W2248598351 hasAuthorship W2248598351A5016059750 @default.
• W2248598351 hasAuthorship W2248598351A5018439413 @default.
• W2248598351 hasAuthorship W2248598351A5041397654 @default.
• W2248598351 hasAuthorship W2248598351A5042701425 @default.
• W2248598351 hasAuthorship W2248598351A5072570716 @default.
• W2248598351 hasConcept C126322002 @default.
• W2248598351 hasConcept C134018914 @default.
• W2248598351 hasConcept C147583825 @default.
• W2248598351 hasConcept C170493617 @default.
• W2248598351 hasConcept C185592680 @default.
• W2248598351 hasConcept C2775864247 @default.
• W2248598351 hasConcept C2777369949 @default.
• W2248598351 hasConcept C2777450907 @default.
• W2248598351 hasConcept C2779638493 @default.
• W2248598351 hasConcept C2779961880 @default.
• W2248598351 hasConcept C53910766 @default.
• W2248598351 hasConcept C71924100 @default.
• W2248598351 hasConcept C98274493 @default.
• W2248598351 hasConceptScore W2248598351C126322002 @default.
• W2248598351 hasConceptScore W2248598351C134018914 @default.
• W2248598351 hasConceptScore W2248598351C147583825 @default.
• W2248598351 hasConceptScore W2248598351C170493617 @default.
• W2248598351 hasConceptScore W2248598351C185592680 @default.
• W2248598351 hasConceptScore W2248598351C2775864247 @default.
• W2248598351 hasConceptScore W2248598351C2777369949 @default.
• W2248598351 hasConceptScore W2248598351C2777450907 @default.
• W2248598351 hasConceptScore W2248598351C2779638493 @default.
• W2248598351 hasConceptScore W2248598351C2779961880 @default.
• W2248598351 hasConceptScore W2248598351C53910766 @default.
• W2248598351 hasConceptScore W2248598351C71924100 @default.
• W2248598351 hasConceptScore W2248598351C98274493 @default.
• W2248598351 hasIssue "2" @default.

• next